Skip to main content
MCRB filings

Corporate insider profile

Eric D. Shaff Filing Activity

Latest reported as Director of Seres Therapeutics, Inc. (MCRB).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,950.27
Latest transaction
May 18, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 18, 2026Seres Therapeutics, Inc. (MCRB)DirectorSale259$7.53$1,950